老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Theravance Biopharma Inc.

17.03
0.0000
成交量：- -
成交额：- -
市值：8.83亿
市盈率：16.30
高：17.03
开：17.03
低：17.03
收：17.03
52周最高：21.03
52周最低：13.08
股本：5,182.83万
流通股本：2,585.69万
量比：- -
换手率：- -
股息：- -
股息率：- -
每股收益(TTM):1.05
每股收益(LYR):2.06
净资产收益率：20.91%
总资产收益率：1.33%
市净率：3.05
市盈率(LYR):8.27

数据加载中...

总览公司新闻资讯公告
2020/02/27

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/02/27

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/24

重要事件披露

Current report, items 2.02 and 9.01
2020/02/18

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/02/13

重要事件披露

Current report, items 1.01, 2.02, 8.01, and 9.01
2020/02/12

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/06

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/30

重要事件披露

Current report, item 5.02
2020/01/28

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/01/13

重要事件披露

Current report, items 7.01 and 9.01
2020/01/08

重要事件披露

Current report, item 8.01
2019/12/26

重要事件披露

Current report, items 1.01, 8.01, and 9.01
2019/12/04

重要事件披露

Current report, items 1.01 and 9.01
2019/11/08

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/11/08

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/11/05

重要事件披露

Current report, items 2.02 and 9.01
2019/10/29

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/09/30

重要事件披露

Current report, item 8.01
2019/09/09

重要事件披露

Current report, items 7.01 and 9.01
更多